New booster vaccine tested for vulnerable adults
NCT ID NCT05303402
Summary
This study tested a new COVID-19 booster shot in adults whose immune systems are weakened by conditions like HIV, kidney disease, or certain medications. The 241 participants received one dose, and researchers tracked their antibody levels and any side effects for a full year. The goal was to see if this specific booster is safe and helps strengthen protection against COVID-19 in this high-risk group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS COV 2 INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ankara University Medical Faculty Hospitals
Ankara, Ankara, 06620, Turkey (Türkiye)
-
Hacettepe University Medical Faculty Hospitals
Ankara, Ankara, 06230, Turkey (Türkiye)
-
Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
-
Hospital Germans Trias i Pujol
Badalona, Barcelona, 08916, Spain
-
Hospital Josep Trueta
Girona, Girona, 17001, Spain
-
Koc University Hospital
Istanbul, Istanbul, 34010, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.